Literature DB >> 1816327

Cholesterol efflux from cells to immunopurified subfractions of human high density lipoprotein: LP-AI and LP-AI/AII.

W J Johnson1, E P Kilsdonk, A van Tol, M C Phillips, G H Rothblat.   

Abstract

Using immunoaffinity chromatography, we separated human high density lipoprotein (HDL) into two subfractions: LP-AI, in which all particles contain apolipoprotein A-I (apoA-I) but no apoA-II, and LP-AI/AII, in which all particles contain both apoA-I and apoA-II. To compare LP-AI and LP-AI/AII as acceptors of cell cholesterol, the isolated subfractions were diluted to 50 micrograms phospholipid/ml, and then incubated with monolayer cultures of cells in which whole-cell and lysosomal cholesterol has been labeled with 14C and 3H, respectively. We used three cell types (Fu5AH rat hepatoma cells, normal human skin fibroblasts, and rabbit aortic smooth muscle cells). When these cells were prepared to contain normal physiological quantities of cholesterol (20-35 micrograms/mg protein), LP-AI and LP-AI/AII were nearly equally efficient in promoting efflux of both whole-cell and lysosomal cholesterol. For whole-cell cholesterol, the rate constants for efflux to LP-AI and LP-AI/AII were: 0.050/h and 0.053/h, respectively, with Fu5AH cells; 0.0063/h and 0.0074/h with GM3468 human skin fibroblasts; and 0.0076/h and 0.0079/h with rabbit aortic smooth muscle cells. When cholesterol in hepatoma cells or fibroblasts was elevated two- to threefold above normal, there was still not difference in efflux of whole-cell cholesterol to LP-AI and LP-AI/AII. In longterm incubations, the net depletion of cholesterol mass from cholesterol-enriched cells was either identical with the two HDL subfractions, or somewhat greater with LP-AI/AII.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1816327

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  17 in total

1.  High-density lipoprotein 3 physicochemical modifications induced by interaction with human polymorphonuclear leucocytes affect their ability to remove cholesterol from cells.

Authors:  A Cogny; V Atger; J L Paul; T Soni; N Moatti
Journal:  Biochem J       Date:  1996-02-15       Impact factor: 3.857

2.  Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.

Authors:  L W Castellani; M Navab; B J Van Lenten; C C Hedrick; S Y Hama; A M Goto; A M Fogelman; A J Lusis
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

3.  HDL3-mediated cholesterol efflux from cultured enterocytes: the role of apoproteins A-I and A-II.

Authors:  G Herold; U Hesse; F Wisst; C Fahr; M Fahr; G Rogler; I Geerling; E F Stange
Journal:  Lipids       Date:  1994-11       Impact factor: 1.880

4.  Apolipoprotein A-II: still second fiddle in high-density lipoprotein metabolism?

Authors:  Alan T Remaley
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02       Impact factor: 8.311

5.  Comparison of the structural and functional effects of monomeric and dimeric human apolipoprotein A-II in high density lipoprotein particles.

Authors:  S Lund-Katz; Y M Murley; E Yon; K L Gillotte; W S Davidson
Journal:  Lipids       Date:  1996-11       Impact factor: 1.880

6.  Human apolipoprotein A-II protects against diet-induced atherosclerosis in transgenic rabbits.

Authors:  Yao Wang; Manabu Niimi; Kazutoshi Nishijima; Ahmed Bilal Waqar; Ying Yu; Tomonari Koike; Shuji Kitajima; Enqi Liu; Tomohiro Inoue; Masayuki Kohashi; Yuka Keyamura; Tomohiro Yoshikawa; Jifeng Zhang; Loretta Ma; Xiaohui Zha; Teruo Watanabe; Yujiro Asada; Y Eugene Chen; Jianglin Fan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-12-13       Impact factor: 8.311

7.  Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux.

Authors:  M C Cheung; A J Mendez; A C Wolf; R H Knopp
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

8.  Cholesterol esters selectively delivered in vivo by high-density-lipoprotein subclass LpA-I to rat liver are processed faster into bile acids than are LpA-I/A-II-derived cholesterol esters.

Authors:  M N Pieters; G R Castro; D Schouten; P Duchateau; J C Fruchart; T J Van Berkel
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

9.  Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia.

Authors:  D S Ng; L A Leiter; C Vezina; P W Connelly; R A Hegele
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

10.  Influence of apolipoprotein A-I and apolipoprotein A-II availability on nascent HDL heterogeneity.

Authors:  Eric T Alexander; Michael C Phillips
Journal:  J Lipid Res       Date:  2013-10-01       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.